Kohjin Bio Co., Ltd.
Research Kohjin Bio Co., Ltd. (177A.T) on Bullrun: market cap JPY 4.33B, P/E 34.2, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker177A.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 4.33B
- P/E34.2
- Dividend yield1.3%
- Financial periodFY2026
- RevenueJPY 4.94B
- Revenue growth-5.1%
- Net incomeJPY 251.02M
- Free cash flow-JPY 280.95M
- Gross margin37.6%
Valuation Snapshot
latest market cap is JPY 4.33B; P/E is 34.2; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 34.19x versus a Healthcare sector median of 21.69x (57.6% above).
Latest dividend yield is 1.26% versus a Healthcare sector median of 2.41% (47.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 4.94B | JPY 251.02M | -JPY 280.95M | 37.6% | 49.11 | JPY 2.49B | JPY 2.19B | JPY 5.95B |
| FY2025 | JPY 5.21B | JPY 794.76M | JPY 28.06M | 45.4% | 157.57 | JPY 3.15B | JPY 2.39B | JPY 5.78B |
| FY2024 | JPY 4.77B | JPY 384.98M | JPY 260.88M | 39.4% | 92.43 | JPY 1.73B | JPY 2.47B | JPY 3.34B |
| FY2023 | JPY 4.74B | JPY 829.79M | -JPY 99.57M | 51.7% | 199.23 | JPY 1.46B | JPY 2.10B | JPY 3.02B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 4.33B | 34.2 | 1.2% | 10 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 10 JPY, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2026 | 10 JPY |
| FY2025 | 24 JPY |
About Kohjin Bio Co., Ltd.
Kohjin Bio Co., Ltd. manufactures and sells animal blood, serum, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics. It operates through Tissue Culture Business, Microbiology Business, and Cell Processing Business segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kohjin Bio Co., Ltd.'s market cap?
Kohjin Bio Co., Ltd.'s market capitalization is JPY 4.33B.
What is Kohjin Bio Co., Ltd.'s P/E ratio?
Kohjin Bio Co., Ltd.'s price-to-earnings (P/E) ratio is 34.2.
Does Kohjin Bio Co., Ltd. pay a dividend?
Kohjin Bio Co., Ltd. has a dividend yield of 1.3%.
What does Kohjin Bio Co., Ltd. do?
Kohjin Bio Co., Ltd. manufactures and sells animal blood, serum, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics. It operates through Tissue Culture Business, Microbiology Business, and Cell Processing Business segments. The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures, as well as hair papilla.